Filing Details

Accession Number:
0001178913-19-001086
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-04-08 16:17:26
Reporting Period:
2019-04-08
Accepted Time:
2019-04-08 16:17:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1158780 Pluristem Therapeutics Inc PSTI Biological Products, (No Disgnostic Substances) (2836) 980351734
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1344740 Zami Aberman Matam Park, Building #5
Haifa L3 3508409
Co-Ceo & Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-04-08 71,429 $0.70 4,939,727 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrant Acquisiton 2019-04-08 71,429 $0.00 71,429 $0.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
71,429 2019-04-08 2024-04-08 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 111,400 Indirect By Rose Hitech Ltd.
Footnotes
  1. The common stock and common stock warrant were acquired in the issuer's public underwritten offering of units, in which each unit consisted of one share of commonstock and an accompanying common stock warrant to purchase one share of common stock, at a price of $0.70 per unit. The price paid per unit is reflected in Table I.
  2. The common stock warrants were exercisable immediately upon their issuance.